AD-2291
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AD-2291, covering 2026-02-27 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Assess the Pharmacokinetics and Safety of AD-229 Compared to AD-2291 in Healthy Adults [Phase 1]